These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 26248473

  • 1. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
    Zhang Y, Wang F, Ding J, Zhang H, Liu X, Wang S, Xiao H, Yao Y, Liu J, Zhong X, Guan N, Su B, Wu G, Yu L.
    Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T, Pohl M, Misselwitz J, John U.
    Kidney Blood Press Res; 2009 Jan; 32(6):440-4. PubMed ID: 20016211
    [Abstract] [Full Text] [Related]

  • 3. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 4. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 5. Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
    Ferrari P, Marti HP, Pfister M, Frey FJ.
    J Hypertens; 2002 Jan; 20(1):125-30. PubMed ID: 11791035
    [Abstract] [Full Text] [Related]

  • 6. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S.
    Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
    [Abstract] [Full Text] [Related]

  • 7. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R, Rios P, Baldovinos G, Chichet MA, Perg N, Sola L, Saona G, De Souza N, Lamadrid V, Gadola L.
    Nephron; 2019 Jul; 143(2):100-107. PubMed ID: 31203280
    [Abstract] [Full Text] [Related]

  • 8. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S, Sar F, Bengi-Bozkurt O, Kazancioglu R.
    Kidney Blood Press Res; 2009 Jul; 32(4):268-75. PubMed ID: 19776644
    [Abstract] [Full Text] [Related]

  • 9. An update on the pathomechanisms and future therapies of Alport syndrome.
    Noone D, Licht C.
    Pediatr Nephrol; 2013 Jul; 28(7):1025-36. PubMed ID: 22903660
    [Abstract] [Full Text] [Related]

  • 10. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 11. Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?
    Hilgers KF, Dötsch J, Rascher W, Mann JF.
    Pediatr Nephrol; 2004 Sep; 19(9):956-61. PubMed ID: 15278690
    [Abstract] [Full Text] [Related]

  • 12. A multidrug, antiproteinuric approach to alport syndrome: a ten-year cohort study.
    Daina E, Cravedi P, Alpa M, Roccatello D, Gamba S, Perna A, Gaspari F, Remuzzi G, Ruggenenti P.
    Nephron; 2015 Sep; 130(1):13-20. PubMed ID: 25895746
    [Abstract] [Full Text] [Related]

  • 13. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 14. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
    Kim HJ, Ryu JH, Han SW, Park IK, Paik SS, Park MH, Paik DJ, Chung HS, Kim SW, Lee JU.
    Nephron Physiol; 2004 Oct; 97(4):p58-65. PubMed ID: 15331931
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 16. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.
    Edström Halling S, Söderberg MP, Berg UB.
    Pediatr Nephrol; 2009 Jan; 24(1):91-7. PubMed ID: 18931859
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
    Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J.
    Diabet Med; 2007 May; 24(5):486-93. PubMed ID: 17367311
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.
    Kaseda R, Tsuchida Y, Gamboa JL, Zhong J, Zhang L, Yang H, Dikalova A, Bian A, Davies S, Fogo AF, Linton MF, Brown NJ, Ikizler TA, Kon V.
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):582-591. PubMed ID: 29691148
    [Abstract] [Full Text] [Related]

  • 19. A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease.
    Manns B, Tonelli M, Culleton B, Faris P, McLaughlin K, Chin R, Gooch K, McAlister FA, Taub K, Thorlacius L, Krause R, Kearns M, Hemmelgarn B, Alberta Kidney Disease Network.
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):565-72. PubMed ID: 22344504
    [Abstract] [Full Text] [Related]

  • 20. Acute renal failure during lisinopril and losartan therapy for proteinuria.
    Hanevold CD.
    Pharmacotherapy; 2006 Sep; 26(9):1348-51. PubMed ID: 16945058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.